Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
In clinical trials, retatrutide has been studied across a range of investigational doses, starting at a low introductory dose and gradually escalating over several weeks
Retatrutide is an investigational once-weekly injectable triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, producing greater appetite suppression and energy expenditure than single or dual receptor agonists
Glutathione in high amounts is not easily tolerated by everyone
In addition, the company now claims on the drops product page that GLP-1 is responsible for a number of health benefits, whereas before the company attributed the benefits to semaglutide
Never try to double up on doses to make up for a potentially weak expired dose
US$ 27.43
US$ 21.57
US$ 20.67
US$ 25.77
